Latin America and the Caribbean vs Lebanon: Percentage of bloodstream infection due to methicillin-resistant
Latin America and the Caribbean
39.0%
in 2022
Lebanon
52.5%
in 2022
Latin America and the Caribbean rank
10th
Lebanon rank
11th
Percentage of bloodstream infection due to methicillin-resistant over time
- Latin America and the Caribbean
- Lebanon
How they compare
Lebanon currently reports 52.5% against 39.0% in Latin America and the Caribbean, a difference of 13.5%.
That makes Lebanon's figure about 1.3 times Latin America and the Caribbean's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Latin America and the Caribbean ahead.
Latin America and the Caribbean ranks 10th and Lebanon ranks 11th of 15 groups.
Across the 2 decades both report, Latin America and the Caribbean averaged higher in 1 and Lebanon in 1.
Head to head by decade
| Decade | Latin America and the Caribbean | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 39.2% | 17.8% | 21.5% | Latin America and the Caribbean |
| 2020s | 40.5% | 41.6% | 1.1% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Latin America and the Caribbean or Lebanon?
- Lebanon, at 52.5% against 39.0% in Latin America and the Caribbean as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Latin America and the Caribbean and Lebanon?
- 13.5%, with Lebanon ahead.
- How many years of comparable data are there for Latin America and the Caribbean and Lebanon?
- 6 years are reported by both, from 2017 to 2022.
- How do Latin America and the Caribbean and Lebanon rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Latin America and the Caribbean ranks 10th and Lebanon ranks 11th of 15 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.